Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Azzalure and Vistabel for Forehead Wrinkles
NCT01014871Phase 2Completed
- Sponsor
- Galderma
- Start
- Jul 2009
- Primary completion
- Apr 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in forehead wrinkles, sponsored by Galderma. Started Jul 2009; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
forehead wrinkles
Beyond the preview
Go deeper on NCT01014871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01014871.